Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison.
T. Tsuda, C. Kyomori, T. Mizukami, T. Taniyama +7 more
2016Molecular and clinical oncology19 citations Open access
Semantic Scholar

